Erika Hamilton: The advances we make every year to improve cancer outcomes are due to clinical trials.

Erika Hamilton shared on LinkedIn:

“Today is World Cancer Research Day.

Clinical trials couldn’t be more important in oncology. The advances we make every year to improve cancer outcomes are due to clinical trials.

Did you know a trial is appropriate at every step of cancer? From cured cancer, to early stage, to metastatic – there are clinical trials for most situations.”

Source Erika Hamilton/LinkedIn

Erika Hamilton is a medical oncologist and the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute (USA). In her role, Dr. Hamilton oversees the research program and clinical trial menu for gynecologic and breast cancer from a medical oncology perspective. Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee a ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.